Protagonist Therapeutics Inc (PTGX)
Operating Income
$58.34M
TTM · Period ending: · USD
PTGX Operating Income
Latest reported$58.34Mperiod ending
Latest reported$58.34Mperiod ending
PTGX Operating Income (-$9.32M → $58.34M)
Annual operating income
High-resolution chart · PNG
PTGX operating income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| -158,127,000 | |
| 252,843,000 | |
| -93,652,000 | |
| -131,373,000 | |
| -125,845,000 | |
| -64,516,000 | |
| -80,521,000 | |
| -42,269,000 | |
| -37,897,000 | |
| -32,666,000 | |
| -14,794,000 | |
| -9,319,000 |